Skip to main content
. 2024 Jul 24;15(9):2061–2077. doi: 10.1007/s13300-024-01622-6

Table 4.

Change in inflammatory markers of the study participants in intervention and control groups (n = 169)

Variables Intervention group Control group Between-group difference (95% CI) p value
Baseline (n = 86) End of 12 weeks (n = 86) Change *p value Baseline (n = 83) End of 12 weeks (n = 83) Change *p value
hs-CRP (mg/L) 5.5 ± 0.6 5.5 ± 0.8 0.0 ± 0.7 0.94 6.7 ± 0.7 7.8 ± 0.8 1.1 ± 0.7 0.23 − 1.1 (− 3.4, 0.8) 0.24
TNFα (pg/ml) 213 ± 24 238 ± 39 25 ± 37 0.26 213 ± 25 311 ± 40 98 ± 38 0.05 73.3 (− 178.1, 31.4) 0.17

Data presented as least square mean ± standard deviation

*p value < 0.05 is considered significant using the paired t test

p value < 0.05 is considered as significant using generalized linear model (GLM)